"Pharmaceutical breakthroughs such as antibiotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry. Pharma introduces brilliant scientists, in-corruptible government regulators, and brave whistleblowers facing off against company executives often blinded by greed. A business that profits from treating ills can create far deadlier problems than it cures. Addictive products are part of the industry's DNA, from the days when corner drugstores sold morphine, heroin, and cocaine, to the past two decades of dangerously overprescribed opioids. Pharma also uncovers the real story of the Sacklers, the family that became one of America's wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the center of the opioid crisis. Relying on thousands of pages of government and corporate archives, dozens of hours of interviews with insiders, and previously classified FBI files, Posner exposes the secrets of the Sacklers' rise to power--revelations that have long been buried under a byzantine web of interlocking companies with ever-changing names and hidden owners. The unexpected twists and turns of the Sackler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. Pharma reveals how and why American drug companies have put earnings ahead of patients." -- Publisher's description

"Why are housing prices in America so unbelievably high, especially in the country's most desirable locations? The superficial answer is "supply and demand," but the deep answer-the reason supply is so low-is draconian housing regulation. In Build, Baby, Build: The Science and Ethics of Housing Regulation, economist Bryan Caplan makes the economic and philosophical case for radical deregulation of this massive market-freeing property owners to build as tall and dense as they wish. Not only would the average price of housing be cut in half, but the building boom unleashed by deregulation would simultaneously reduce inequality, increase social mobility, promote economic growth, reduce homelessness, increase birth rates, and help the environment. It's surprising then, that despite all these benefits, housing deregulation is universally unpopular with policymakers. Combining visually stunning graphics and careful interdisciplinary research, Build, Baby, Build, takes readers on a journey through what is wrong with the housing market-and what we can do about it"--

In this book, Nobel Laureate Merton Miller presents a sustained attack on the popular view that modern financial innovations have created excessive market volatility to the detriment of individual savers and business investors, and that regulation is essential in such forms as higher margin requirements, taxes on trading, and perhaps even closing down the future market.

First published in 1943, this work contains five interconnected essays presenting M. Kalecki's renowned additions to the business cycle theory. Written by one of the most distinguished economists of the 20th century, this work will be essential reading for students and scholars of the history of economic thought, monetary theory and macroeconomics.